Our study adds new data regarding the effect of the TGF-β1 gene -509C/T promoter polymorphism on serum acid-activated latent TGF-β1 quantities in healthy subjects and patients with colorectal cancer. The gene discussed is TGFB1; the disease is colorectal cancer.